A1 Refereed original research article in a scientific journal
Independent Prediction of Child Psychiatric Symptoms by Maternal Mental Health and Child Polygenic Risk Scores
Authors: Chen, Lawrence M.; Pokhvisneva, Irina; Lahti-Pulkkinen, Marius; Kvist, Tuomas; Baldwin, Jessie R.; Parent, Carine; Silveira, Patricia P.; Lahti, Jari; Räikkönen, Katri; Glover, Vivette; O’Connor, Thomas G.; Meaney, Michael J.; O’Donnell, Kieran J.
Publisher: Elsevier Inc.
Publication year: 2024
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Journal name in source: Journal of the American Academy of Child and Adolescent Psychiatry
Volume: 63
Issue: 6
First page : 640
Last page: 651
ISSN: 0890-8567
eISSN: 1527-5418
DOI: https://doi.org/10.1016/j.jaac.2023.08.018
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://doi.org/10.1016/j.jaac.2023.08.018
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/380717013
Self-archived copy's licence: CC BY NC ND
Self-archived copy's version: Publisher`s PDF
Objective
Prenatal maternal symptoms of depression and anxiety are associated with an increased risk for child socioemotional and behavioral difficulties, supporting the fetal origins of mental health hypothesis. However, to date, studies have not considered specific genomic risk as a possible confound.
MethodThe Avon Longitudinal Study of Parents and Children (ALSPAC) cohort (n = 5,546) was used to test if child polygenic risk score for attention-deficit/hyperactivity disorder (ADHD), schizophrenia, or depression confounds or modifies the impact of prenatal maternal depression and anxiety on child internalizing, externalizing, and total emotional/behavioral symptoms from age 4 to 16 years. Longitudinal child and adolescent symptom data were analyzed in the ALSPAC cohort using generalized estimating equations. Replication analyses were done in an independent cohort (Prevention of Preeclampsia and Intrauterine Growth Restriction [PREDO] cohort; n = 514) from Finland, which provided complementary measures of maternal mental health and child psychiatric symptoms.
ResultsMaternal depression and anxiety and child polygenic risk scores independently and additively predicted behavioral and emotional symptoms from childhood through mid-adolescence. There was a robust prediction of child and adolescent symptoms from both prenatal maternal depression (generalized estimating equation estimate = 0.093, 95% CI 0.065-0.121, p = 2.66 × 10−10) and anxiety (generalized estimating equation estimate = 0.065, 95% CI 0.037-0.093, p = 1.62 × 10−5) after adjusting for child genomic risk for mental disorders. There was a similar independent effect of maternal depression (B = 0.156, 95% CI 0.066-0.246, p = .001) on child symptoms in the PREDO cohort. Genetically informed sensitivity analyses suggest that shared genetic risk only partially explains the reported association between prenatal maternal depression and offspring mental health.
ConclusionThese findings highlight the genomic contribution to the fetal origins of mental health hypothesis and further evidence that prenatal maternal depression and anxiety are robust in utero risks for child and adolescent psychiatric symptoms.
Downloadable publication This is an electronic reprint of the original article. |